Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
2,869
-115
-4% -$39.4K 0.18% 86
2026
Q1
$1.05M Sell
2,984
-10
-0.3% -$3.56K 0.2% 83
2025
Q4
$980K Sell
2,994
-30
-1% -$9.52K 0.18% 87
2025
Q3
$853K Buy
3,024
+245
+9% +$71.1K 0.17% 96
2025
Q2
$776K Hold
2,779
0.19% 85
2025
Q1
$866K Hold
2,779
0.21% 81
2024
Q4
$724K Sell
2,779
-98
-3% -$29.1K 0.17% 89
2024
Q3
$927K Buy
2,877
+63
+2% +$20.6K 0.21% 78
2024
Q2
$879K Sell
2,814
-30
-1% -$8.81K 0.22% 76
2024
Q1
$809K Hold
2,844
0.2% 82
2023
Q4
$819K Sell
2,844
-33
-1% -$8.99K 0.21% 80
2023
Q3
$773K Sell
2,877
-1,800
-38% -$449K 0.22% 79
2023
Q2
$1.04M Buy
4,677
+243
+5% +$56.4K 0.29% 73
2023
Q1
$1.07M Sell
4,434
-51
-1% -$12.5K 0.32% 72
2022
Q4
$1.18M Buy
+4,485
New +$1.2M 0.36% 69

Other funds holding AMGN

Legacy Trust's AMGN Position: Q2 2026 in Review

Legacy Trust reduced its Amgen (AMGN) stake by 3.9% in Q2 2026, selling an estimated $39.4K and leaving 2,869 shares worth $1.04M. The position accounts for 0.18% of the portfolio, ranked #86.

Legacy Trust first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.18M in Q4 2022. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Legacy Trust held 2,869 shares of Amgen worth $1.04M as of Q2 2026.
  • Legacy Trust sold 115 Amgen shares in Q2 2026, an estimated $39.4K.
  • Amgen made up 0.18% of Legacy Trust's portfolio in Q2 2026, its #86 holding.
  • Legacy Trust first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • Legacy Trust's Amgen position peaked at $1.18M in Q4 2022.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Legacy Trust's 13F filing for Q2 2026, filed 31 Jul 2026.